Related references
Note: Only part of the references are listed.Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib
Tessa van Balen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
ADAMTS13 Antibody Depletion by Bortezomib in Thrombotic Thrombocytopenic Purpura
Jake Shortt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Antibody Depletion by Bortezomib through Blocking of Antigen Presentation
Se Jin Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Proteasome Inhibition Profoundly Affects Activated Human B Cells
Arend Mulder et al.
TRANSPLANTATION (2013)
Bortezomib for Acute Antibody-Mediated Rejection in Liver Transplantation
F. Paterno et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Autoimmune Thrombotic Microangiopathy: Advances in Pathogenesis, Diagnosis, and Management
Han-Mou Tsai
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
Marie Scully et al.
BLOOD (2011)
Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature
Mischelle A. Elliott et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Bortezomib: A novel chemotherapeutic agent for hematologic malignancies
Kyle N. Utecht et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse
Ming Jin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection
Matthew J. Everly et al.
TRANSPLANTATION (2008)
Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura
Wilmar Patino et al.
JOURNAL OF CLINICAL APHERESIS (2007)
Share Paper
